Alpha Tau Medical (DRTS) Non-Current Assets (2020 - 2026)
Alpha Tau Medical (DRTS) reported Non-Current Assets of $27.4 million for Q1 2026, up 13.6% on a YoY basis from $24.1 million in Q1 2025, and little changed sequentially from $27.4 million in Q4 2025.
Alpha Tau Medical (DRTS) Non-Current Assets (2020 - 2026) Analysis & Trends
Alpha Tau Medical (DRTS) has 7 years of Non-Current Assets data on file, last reported at $27.4 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets rose 13.6% year-over-year to $27.4 million; the trailing twelve-month figure through Mar 2026 stood at $27.4 million (up 13.6% YoY), and the FY2025 full-year result was $27.4 million, up 24.48% from the prior year.
- Non-Current Assets steadied at $27.4 million in Q1 2026, from $27.4 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $7.8 billion in Q1 2022 to a low of $8.0 million in Q2 2022.
- A 5-year average of $479.4 million and a median of $21.2 million in 2024 frame the typical range for Non-Current Assets.
- Peak annual rise in Non-Current Assets reached 90.46% in 2023, while the deepest fall reached 99.81% in 2023.
- Tracing DRTS's Non-Current Assets over 5 years: stood at $13.7 million in 2022, then soared by 58.22% to $21.6 million in 2023, then grew by 1.59% to $22.0 million in 2024, then advanced by 24.48% to $27.4 million in 2025, then rose by 0.26% to $27.4 million in 2026.
- Business Quant data shows DRTS's Non-Current Assets at $27.4 million in Q1 2026, $27.4 million in Q4 2025, and $27.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 5.83 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.95 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 285.82 Mn |
| 10 | Alpha Tau Medical | 1.12 Bn | 1.04 Bn | - | 27.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.43 Mn |
| Dec 31, 2025 | 27.35 Mn |
| Sep 30, 2025 | 27.59 Mn |
| Jun 30, 2025 | 25.18 Mn |
| Mar 31, 2025 | 24.14 Mn |
| Dec 31, 2024 | 21.98 Mn |
| Sep 30, 2024 | 20.94 Mn |
| Jun 30, 2024 | 20.80 Mn |
| Mar 31, 2024 | 21.24 Mn |
| Dec 31, 2023 | 21.63 Mn |
| Sep 30, 2023 | 15.30 Mn |
| Jun 30, 2023 | 15.15 Mn |
| Mar 31, 2023 | 15.03 Mn |
| Dec 31, 2022 | 13.67 Mn |
| Sep 30, 2022 | 8.04 Mn |
| Jun 30, 2022 | 7.95 Mn |
| Mar 31, 2022 | 7.84 Bn |
| Dec 31, 2021 | 9.57 Mn |
| Dec 31, 2020 | 5.53 Mn |